We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.

The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.

Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Coverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...

Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...

The assassination of UnitedHealthcare CEO Brian Thompson triggered a disturbing avalanche of sympathy for the suspected ...

Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...

Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t ...